Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis-related signaling molecules comprise a diverse group of proteins that propagate and regulate the cell death program. Central families include the caspases (executors), Bcl-2 family (regulators of mitochondrial integrity), inhibitor of apoptosis proteins (inhibit caspase action), and cell-surface death receptors (e.g., Fas/CD95, TNFR family). These molecules operate across intrinsic (mitochondrial) and extrinsic (receptor-mediated) signaling pathways, tightly controlling cellular suicide to maintain homeostasis, prevent cancer, mediate immune responses, and prevent developmental anomalies. The pathways are interconnected by key regulators such as FADD, SMAC/DIABLO, and various kinases (e.g., MAPK, JAK/STAT). Although individual family members often serve as drug targets or biomarkers for disease, the term "apoptosis-related signaling molecules" itself is a collective designation and does not identify a unique target[2][4][6][8][9].
Inhibition of anti-apoptotic proteins (IAP, Bcl-2 family) Activation of death receptors (Fas, TNFR) Promotion/inhibition of caspase activity Modulation of signaling cascades (MAPK, JAK/STAT)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis-related signaling molecules.